# GMP CO LTD · 66-41 · VIETNAM — FDA import alert red lists: firms subject to detention without physical examination

For GMP CO LTD · 66-41 · VIETNAM, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is VIETNAM; product is Linsen Double Caulis Capsules; product code is 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C; date published is 10/22/2025; address is Dan Phuong Industrial V , Nam Dan, VIETNAM, verified against its source on 2026-09-16.

- **Firm:** GMP CO LTD _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** VIETNAM _(verified: appears in the quote below)_
- **Address:** Dan Phuong Industrial V , Nam Dan, VIETNAM _(verified: appears in the quote below)_
- **Date published:** 10/22/2025 _(verified: appears in the quote below)_
- **Product code:** 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. _(verified: appears in the quote below)_
- **Product:** Linsen Double Caulis Capsules _(verified: appears in the quote below)_
- **FDA notes:** Linsen Double Caulis Capsules is a drug as defined by section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because it is an article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body. Statements in product labeling that provide evidence of the intended use of the product include, but may not be limited to, the following: “Traditionally used for relief of backache, lumbago, sinew and cartilage.” _(verified: appears in the quote below)_

## What the source says

> GMP CO LTD Date Published : 10/22/2025 Dan Phuong Industrial V , Nam Dan, VIETNAM 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 10/22/2025 Desc: Linsen Double Caulis Capsules Notes: Linsen Double Caulis Capsules is a drug as defined by section 201(g)(1) of the FD&C Act, 21 U.S.C. 321(g)(1), because it is an article intended for use in the diagnosis, cure, mitigation, treatment, or prevention of disease and/or intended to affect the structure or function of the body. Statements in product labeling that provide evidence of the intended use of the product include, but may not be limited to, the following: “Traditionally used for relief of backache, lumbago, sinew and cartilage.”

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).